Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Lipsitch

Showing results (181-190 of 446) with videos related to

Pageof 45
Sort By:
American Journal of Epidemiology|January 29, 2019
THE AUTHORS REPLYJoseph A Lewnard, Christine Tedijanto, Benjamin J Cowling, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 19, 2018
Estimating the proportion of bystander selection for antibiotic resistance among potentially pathogenic bacterial floraChristine Tedijanto, Scott W Olesen, Yonatan H Grad, et al.
The Lancet. Infectious Diseases|December 5, 2016
Monitoring the fitness of antiviral-resistant influenza strains during an epidemic: a mathematical modelling studyKathy Leung, Marc Lipsitch, Kwok Yung Yuen, et al.
Mbio|June 7, 2024
Considerations for viral co-infection studies in human populationsTaylor Chin, Ellen F Foxman, Timothy A Watkins, et al.
Sexually Transmitted Diseases|October 9, 2002
Projection of the future dimensions and costs of the genital herpes simplex type 2 epidemic in the United StatesDavid N Fisman, Marc Lipsitch, Edward W Hook, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 22, 2018
The Relative Impact of Community and Hospital Antibiotic Use on the Selection of Extended-spectrum Beta-lactamase-producing Escherichia coliDerek R MacFadden, David N Fisman, William P Hanage, et al.
Epidemics|March 1, 2011
No coexistence for free: neutral null models for multistrain pathogensMarc Lipsitch, Caroline Colijn, Ted Cohen, et al.
Lancet (London, England)|November 14, 2016
Fractional dosing of yellow fever vaccine to extend supply: a modelling studyJoseph T Wu, Corey M Peak, Gabriel M Leung, et al.
Plos Medicine|January 12, 2007
Pandemic influenza: risk of multiple introductions and the need to prepare for themChristina E Mills, James M Robins, Carl T Bergstrom, et al.
Plos Biology|November 13, 2019
Surveillance to maintain the sensitivity of genotype-based antibiotic resistance diagnosticsAllison L Hicks, Stephen M Kissler, Marc Lipsitch, et al.
Pageof 45

Showing results (181-190 of 446) with videos related to

Sort By:
Pageof 45
American Journal of Epidemiology|January 29, 2019
THE AUTHORS REPLYJoseph A Lewnard, Christine Tedijanto, Benjamin J Cowling, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 19, 2018
Estimating the proportion of bystander selection for antibiotic resistance among potentially pathogenic bacterial floraChristine Tedijanto, Scott W Olesen, Yonatan H Grad, et al.
The Lancet. Infectious Diseases|December 5, 2016
Monitoring the fitness of antiviral-resistant influenza strains during an epidemic: a mathematical modelling studyKathy Leung, Marc Lipsitch, Kwok Yung Yuen, et al.
Mbio|June 7, 2024
Considerations for viral co-infection studies in human populationsTaylor Chin, Ellen F Foxman, Timothy A Watkins, et al.
Sexually Transmitted Diseases|October 9, 2002
Projection of the future dimensions and costs of the genital herpes simplex type 2 epidemic in the United StatesDavid N Fisman, Marc Lipsitch, Edward W Hook, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 22, 2018
The Relative Impact of Community and Hospital Antibiotic Use on the Selection of Extended-spectrum Beta-lactamase-producing Escherichia coliDerek R MacFadden, David N Fisman, William P Hanage, et al.
Epidemics|March 1, 2011
No coexistence for free: neutral null models for multistrain pathogensMarc Lipsitch, Caroline Colijn, Ted Cohen, et al.
Lancet (London, England)|November 14, 2016
Fractional dosing of yellow fever vaccine to extend supply: a modelling studyJoseph T Wu, Corey M Peak, Gabriel M Leung, et al.
Plos Medicine|January 12, 2007
Pandemic influenza: risk of multiple introductions and the need to prepare for themChristina E Mills, James M Robins, Carl T Bergstrom, et al.
Plos Biology|November 13, 2019
Surveillance to maintain the sensitivity of genotype-based antibiotic resistance diagnosticsAllison L Hicks, Stephen M Kissler, Marc Lipsitch, et al.
Pageof 45